Stocktoria

Clene Inc. CLNN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-08-27

Clene Inc. statistics & valuation

Market cap$77.4M
Net margin-13086.5%
FCF margin-9292.5%
Net debt$12.6M
Enterprise value USD$90.0M
Earnings yield EBIT/EV-25.6%
Return on capital-313.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-9357.80% -1347.20% -6325.20% -7569.40% -11520.50% -13086.50% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-9812.60% -6912.60% -10234.50% -6198.80% -9676.30% -11541.50% 2019202020212022202320242025
Return on equity (%)
-5653.10% -77.30% -924.30% -369.70% 2019202020212022202320242025
Shares outstanding
17.4M 59.5M 62.3M 74.8M 6.4M 8.1M 10.8M 2019202020212022202320242025
Net debt ($)
$12.6M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-108.60% -28.20% -15.40% -67.20% -94.60% -144.10% -144.40% 2019202020212022202320242025
Free cash flow margin (%)
-9376.70% -4973.20% -9342.50% -4663.80% -6240.10% -9292.50% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-11541.5%-9676.3%-6198.8%-10234.5%-6912.6%-9812.6%—
Net margin-13086.5%-11520.5%-7569.4%-6325.2%-1347.2%-9357.8%—
FCF margin-9292.5%-6240.1%-4663.8%-9342.5%-4973.2%-9376.7%—
Return on assets-144.4%-144.1%-94.6%-67.2%-15.4%-28.2%-108.6%
Return on equity148.8%444.8%-369.7%-924.3%-77.3%-5653.1%23.8%
Debt / equity-1.01×——————
Current ratio0.831.571.532.119.065.402.20

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.